Healthcare News
FDA Accepts Nanoscope`s BLA for Optogenetic Gene Therapy Mogenry in Retinitis Pigmentosa
The FDA has accepted and filed Nanoscope Therapeutics’ biologics license application (BLA) for Mogenry (sonpiretigene isteparvovec; MCO-010), an investigational optogenetic gene therapy designed to restore vision in patients with retinitis pigmentosa (RP) and severe vision loss.
Source: eyewire
Could this common bacteria in the eye be driving Alzheimer's disease?
A new study found that a common type of bacteria that causes sinus infections may stay in the eye for many years, potentially increasing a person’s risk for developing Alzheimer’s disease. Scientists believe the identification of these bacteria may help detect and develop new treatment options for Alzheimer’s disease.
Source: Medical News Today
Aging blocks the retina's ability to regrow lost neurons, a first-of-its-kind study finds
A new study from the laboratory of Levi Todd, Ph.D., at Upstate Medical University has found that aging significantly limits the ability of support cells in the retina, called glia, to be reprogrammed into new neurons, a finding with important implications for the future of regenerative medicine for age-related neurodegenerative diseases such as Alzheimer's, Parkinson's and glaucoma.
Source: Medical Xpress
Early surgery for bacterial eye infection offers hope to patients
Early vitrectomy surgery for acute endophthalmitis, a rare eye condition, may potentially benefit patients' vision more than the current antibiotic-first approach, according to a study led by researchers at University College London (UCL) and Moorfields Eye Hospital.
Source: Medical Xpress
Virtual reality-based digital defocus vision training may aid myopia in children
Virtual reality-based digital defocus vision training (DDVT) may be a promising adjunctive approach for pediatric myopia control, according to a study published online Aug. 27 in JAMA Ophthalmology.
Source: Medical Xpress
